» Articles » PMID: 39329369

Involvement of a Battery of Investigated Genes in Lipid Droplet Pathophysiology and Associated Comorbidities

Overview
Journal Adipocyte
Date 2024 Sep 27
PMID 39329369
Authors
Affiliations
Soon will be listed here.
Abstract

Lipid droplets (LDs) are highly specialized energy storage organelles involved in the maintenance of lipid homoeostasis by regulating lipid flux within white adipose tissue (WAT). The physiological function of adipocytes and LDs can be compromised by mutations in several genes, leading to NEFA-induced lipotoxicity, which ultimately manifests as metabolic complications, predominantly in the form of dyslipidemia, ectopic fat accumulation, and insulin resistance. In this review, we delineate the effects of mutations and deficiencies in genes - , , , , , , , , , and - involved in lipid droplet metabolism and their associated pathophysiological impairments, highlighting their roles in the development of lipodystrophies and metabolic dysfunction.

References
1.
Russo L, Ghadieh H, Ghanem S, Al-Share Q, Smiley Z, Gatto-Weis C . Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. J Lipid Res. 2016; 57(12):2163-2175. PMC: 5321226. DOI: 10.1194/jlr.M072066. View

2.
Wu Z, Xie Y, Morrison R, BUCHER N, Farmer S . PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes. J Clin Invest. 1998; 101(1):22-32. PMC: 508536. DOI: 10.1172/JCI1244. View

3.
Savage D, Agostini M, Barroso I, Gurnell M, Luan J, Meirhaeghe A . Digenic inheritance of severe insulin resistance in a human pedigree. Nat Genet. 2002; 31(4):379-84. DOI: 10.1038/ng926. View

4.
Gupta M, De Jesus D, Kahraman S, Valdez I, Shamsi F, Yi L . Insulin receptor-mediated signaling regulates pluripotency markers and lineage differentiation. Mol Metab. 2018; 18:153-163. PMC: 6308035. DOI: 10.1016/j.molmet.2018.09.003. View

5.
Lambadiari V, Kountouri A, Maratou E, Liatis S, Dimitriadis G, Karpe F . Case Report: Metreleptin Treatment in a Patient With a Novel Mutation for Familial Partial Lipodystrophy Type 3, Presenting With Uncontrolled Diabetes and Insulin Resistance. Front Endocrinol (Lausanne). 2021; 12:684182. PMC: 8217860. DOI: 10.3389/fendo.2021.684182. View